32 results
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties and any right
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
by law and/or otherwise permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties
8-K
EX-10.1
rtpr gvw66b6jg
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K/A
EX-99.3
8b0gwrp4 agp9z9m
3 Feb 21
Other Events
4:59pm
8-K
4sowbin6p6c8he7e
9 Dec 20
Other Events
5:27pm
425
ozlyyn fl
9 Dec 20
Business combination disclosure
5:25pm
8-K
EX-99.1
30qm1 6kep
4 Dec 20
Other Events
5:17pm
425
EX-99.1
gb1psxa
4 Dec 20
Business combination disclosure
5:16pm
S-4/A
EX-10.23
6f3 joexg0tl26da
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4/A
EX-10.21
pqhvnxxt7vc10u9cs5y
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
8-K
EX-2.2
f4jqfu 43ky3ls
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.2
nptx3pr
24 Aug 20
Business combination disclosure
5:28pm